Entrada Therapeutics, Inc. (TRDA) has a market capitalization of $537.13M and trades at $14.03. The 52-week range is 4.93-13.66.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -4, Earnings Per Share (EPS) of $-3.47, annual revenue of $25.42M.
The stock has a beta of -0.15, operates in the Healthcare sector.
